Evid Invest

Earnings calendar/INM

InMed Pharmaceuticals Inc. (INM)

Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.

Latest filed quarter

The most recent quarter InMed Pharmaceuticals Inc. has filed, from EvidInvest's standardized statements.

Period end

Jun 30, 2026

Q4 FY2026

Filed

Sep 9, 2026

View the filing

EPS (diluted)

$-1.44

Est. $-94.44 · +98.5%

Revenue

Est. $2.06B · —

Net income

$-5.8M

As filed

EPS YoY

-1957.1%

vs quarter ended 2025-06-30

Revenue YoY

vs quarter ended 2025-06-30

Next report

Sep 23, 2026

Scheduled · est. EPS $-94.44

Run-rate

Trailing twelve months, summed from the last four filed quarters.

TTM EPS (diluted)

$-3.12

2025-09-30 through 2026-06-30

TTM revenue

2025-09-30 through 2026-06-30

Filed quarters

40

On record here

EPS at or above estimate (4Q)

75%

Of the last four quarters that carry an estimate

Filed quarters

One row per filed statement, newest first

Period endFiledEPS dilutedRevenueEPS YoYRevenue YoYEst. EPSSurprise
2026-06-30Q4 FY20262026-09-09$-1.44-1957.1%$-94.44+98.5%
2026-03-31Q3 FY20262026-05-06$-0.73$0+62.4%-100.0%$-94.44+99.2%
2025-12-31Q2 FY20262026-02-11$-0.51$820,188+86.0%-26.2%
2025-09-30Q1 FY20262025-11-06$-0.44$1.1M+83.8%-11.4%
2025-06-30Q4 FY20252025-09-23$-0.07$1.3M-102.9%+1.7%
2025-03-31Q3 FY20252025-05-12$-1.94$1.3M+45.8%+7.6%
2024-12-31Q2 FY20252025-02-12$-3.64$1.1M+1.9%-10.4%
2024-09-30Q1 FY20252024-11-14$-2.71$1.3M+82.2%+40.2%$0.02-17697.4%
2024-06-30Q4 FY20242024-09-30$2.39$1.3M+3.0%-44.5%$-85.00+102.8%
2024-03-31Q3 FY20242025-05-12$-3.58$1.2M-496.7%+13.4%$1.58-326.6%
2023-12-31Q2 FY20242024-02-13$-3.71$1.2M-307.7%+164.0%$2.09-277.5%
2023-09-30Q1 FY20242023-11-14$-15.24$901,862-275.4%+181.1%$1.39-1196.4%
2023-06-30Q4 FY20232023-09-29$2.32$2.3M+117.7%+349.0%$-85.00+102.7%
2023-03-31Q3 FY20232023-05-15$-0.60$1.0M+90.2%+234.0%$-90.00+99.3%
2022-12-31Q2 FY20232023-02-17$-0.91$469,783+88.2%+77.2%$-90.00+99.0%
2022-09-30Q1 FY20232022-11-14$-4.06$320,788+34.2%$-0.85-377.6%
2022-06-30Q4 FY20222022-09-23$-13.13$514,758+64.4%-41.5%$-1.10-1093.6%
2022-03-31Q3 FY20222022-05-13$-6.14$309,585-1397.6%-29.2%$-1.15-433.9%
2021-12-31Q2 FY20222022-02-14$-7.73$265,092-1989.2%-4.2%$-1.20-544.2%
2021-09-30Q1 FY20222021-11-10$-6.17$0-1890.3%$-175.00+96.5%
2021-06-30Q4 FY20212021-09-24$-36.87$880,634-12190.0%$-170.00+78.3%
2021-03-31Q3 FY20212021-05-13$-0.41$437,309-5.1%$-120.00+99.7%
2020-12-31Q2 FY20212021-02-11$-0.37$276,790+22.9%$-120.00+99.7%
2020-09-30Q1 FY20212020-12-17$-0.31$0+42.6%
2020-06-30Q4 FY20202021-09-24$-0.30$0+99.9%$-0.66+54.5%
2020-03-31Q3 FY20202021-05-13$-0.39$0+99.8%$-0.66+40.9%
2019-12-31Q2 FY20202021-02-11$-0.48$0+99.6%$-0.66+27.3%
2019-09-30Q1 FY20202020-12-17$-0.54$0+99.6%$-0.66+18.2%
2019-06-30Q4 FY20192019-06-30$-204.50$0-26.9%$-0.66-30884.8%
2019-03-31Q3 FY20192019-03-31$-168.10$0-45.0%$-0.33-50839.4%
2018-12-31Q2 FY20192018-12-31$-128.10$0-33.3%
2018-09-30Q1 FY20192018-09-30$-137.20$0-19.6%
2018-06-30Q4 FY20182018-06-30$-161.10$0+6.9%
2018-03-31Q3 FY20182018-03-31$-115.90$0-22.6%
2017-12-31Q2 FY20182017-12-31$-96.10$0-9.5%
2017-09-30Q1 FY20182017-09-30$-114.70$0-140.0%
2017-06-30Q4 FY20172017-06-30$-173.00$0
2017-03-31Q3 FY20172017-03-31$-94.50$0
2016-12-31Q2 FY20172016-12-31$-87.80$0
2016-09-30Q1 FY20172016-09-30$-47.80$0
EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.